Hirschsprung Disease Genetic Study

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 4 versions Re-verified since Nov 28, 2023, no change to tracked fieldsv22-v25
  2. Primary and study completion dates: Aug 2025 to Dec 2028v21
  3. Re-verified, no change to tracked fieldsv20
  4. Primary and study completion dates: Mar 2025 to Aug 2025v19
  5. Site contact updatedv18
Show 16 earlier versionsHide 16 earlier versions
  1. 2 versions Re-verified since Sep 6, 2019, no change to tracked fieldsv16-v17
  2. Site contact updated
    • Study description shortened, about 4 words
    v15
  3. Re-verified, no change to tracked fieldsv14
  4. Lead sponsor: Johns Hopkins University to NYU Langone Health
    • Study site revised
    • Collaborators expanded, about 3 words
    v13
  5. Primary endpoints: 1 to 3v12 Show 4 more changesShow less
    • Eligibility criteria revised
    • Secondary endpoints: 1 to 8
    • Study description expanded, about 177 words
    • Publications: 6 to 7
  6. Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Johns Hopkins Universityv11
  7. Primary completion date: Mar 2020 to Mar 2025
    • Study completion date: Mar 2025
    • Publications: 5 to 6
    v10
  8. Study description shortened, about 112 wordsv9
  9. Enrollment target: 2000 to 3000
    • Primary completion date: Mar 2020
    • Eligibility criteria expanded, about 26 words
    v8
  10. Study description expanded, about 11 words
    • Publications: 4 to 5
    v7
  11. Study completion date: Mar 2010 to not stated
    • Eligibility criteria revised
    • Study description expanded, about 14 words
    • Publications: 3 to 4
    v6
  12. Study completion date: Mar 2009 to Mar 2010
    • Study description expanded, about 9 words
    v5
  13. 3 versions Re-verified since Aug 1, 2007, no change to tracked fieldsv2-v4
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.
Trial Details
NCT Number NCT00478712
Lead Sponsor NYU Langone Health
Collaborators: New York University
Conditions
(from sponsor)		 Hirschsprung Disease
Related terms Hirschsprung Disease
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov